Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Dovetail Genomics LLC Micro-C Service

Closed
75N98026Q00789Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
Atomically Precise Molecules (APM)
Solicitation # DARPA-PS-26-141
The Atomically Precise Molecules (APM) program, solicitation DARPA-PS-26-141, is a 36-month initiative by the DARPA Multi X Office seeking innovative synthesis techniques for programmable precision polymers (PPPs) and nonlinear optical (NLO) materials. The program aims to develop scalable materials with strictly controlled monomer sequences and compositions, culminating in a prototype NLO material integrated into a government-provided electro-optic modulator capable of achieving greater than 1THz modulation. The effort is structured in two phases, with Phase I lasting 12 months and focusing on synthesis capabilities. Research limited to inorganic materials or incremental improvements to existing state-of-the-art practices is specifically excluded. Awards will be issued as Other Transaction for Prototype Agreements, with payments processed through the Wide Area Workflow system based on a schedule of milestones. Proposals are due by December 18, 2026, via the Broad Agency Announcement Tool and must include technical, management, and pricing volumes. Eligibility is restricted to U.S. organizations, and all performers must comply with CMMC Level 2 self-certification and NIST SP 800-171 standards for safeguarding Controlled Unclassified Information. Evaluation will be based on technical approach, relevance to the DARPA mission, budget realism, and the capability to transition the technology to military or commercial sectors.
Defense Advanced Research Projects Agcy

POSTED

about 15 hours ago

DEADLINE

in about 2 months
NAICS: 541715
New
Federal
Request for Proposal (RFP) - Resilient Missile Warning Tracking (RMWT) Low Earth Orbit (LEO) Ground Entry Points (GEPs)
Solicitation # FA240126R0003
The Space Development Agency is soliciting proposals under solicitation FA240126R0003 for the Resilient Missile Warning Tracking Low Earth Orbit Ground Entry Points effort. This acquisition is structured as an Indefinite Delivery Indefinite Quantity contract with a ceiling of 369 million dollars, covering the development, integration, test, operations, and maintenance of Tranche 3 Ground Entry Points at multiple globally dispersed locations. The scope of work encompasses civil engineering from detailed design through construction, the procurement and installation of communications shelters, antennas, optical terminals, and networking equipment, as well as the development of Ground Support Equipment and Auxiliary Development Units. The contract includes an ordering period from March 31, 2027, to September 30, 2031, with option periods extending through September 30, 2035. Award will be determined using a best value tradeoff process where technical, management, and past performance factors are combined and considered significantly more important than price. The technical evaluation focuses on the understanding of requirements, feasibility of approach, and scalability, while management is assessed based on project and schedule management, subcontractor oversight, and security handling. Proposals must be submitted in seven volumes via the DoD Secure Access File Exchange by 4:00 PM Eastern Time on November 23, 2026. Large business primes are required to meet a minimum quantitative requirement of 5 percent small business participation. The contract utilizes a mix of Firm Fixed Price for primary labor and materials and Cost Reimbursable arrangements for other direct costs and travel.
FA2401 Space Development Agency Sda

POSTED

about 15 hours ago

DEADLINE

in 27 days
NAICS: 541715
New
Federal
Pioneering Aerospace Capabilities, Engineering and Research
Solicitation # FA2391-23-S-2403
The Pioneering Aerospace Capabilities, Engineering and Research (PACER) program, under solicitation FA2391-23-S-2403, is a comprehensive Broad Agency Announcement issued by the Air Force Research Laboratory (AFRL) Aerospace Systems Directorate. This open, two-step solicitation is designed to fund research and development efforts that mature novel aerospace concepts and technologies to appropriate technology readiness levels, specifically targeting transformative capabilities for the warfighter. The program encompasses a wide array of specialized calls, including efforts for hypersonic weapon concepts (HAMWC), automated air-to-air refueling (CRONUS), advanced propulsion and power systems (SNAPP, AEPO, MSIPPT, HITEMP, INNATE), and multidisciplinary design and structures (MASTR, VOLARE, CC DROIDS). The acquisition process typically involves an initial white paper submission followed by full proposals from selected offerors, though some calls utilize a one-step process. Awards may take the form of contracts or assistance instruments, with anticipated types including Cost Plus Fixed Fee (CPFF), Firm-Fixed-Price (FFP), and IDIQ task orders. Due to the sensitive nature of the research, strict security protocols are enforced, requiring offerors to comply with AFRLI 61-113 for Science and Technology Protection and meet CMMC Level 2 and NIST SP 800-171 standards to access Controlled Unclassified Information (CUI). Proposals are evaluated based on the uniqueness and innovation of the approach, understanding of scope, technical soundness, and transition potential, with cost realism serving as a secondary substantial factor.
FA2391 USAF Afmc Afrl Pzl Afrl Rqkp

POSTED

about 15 hours ago

DEADLINE

in over 4 years

AI Contract Overview

Show more

Dovetail Genomics LLC will provide Micro-C sequencing services to support NCI/CCR/LRBGE research on how substrate stiffness influences 3D chromatin architecture in colon cancer cell lines. The project involves processing eight government-provided samples using Dovetail’s proprietary Micro-C protocol, which leverages micrococcal nuclease digestion to produce highly uniform fragments for precise nucleosome-level resolution and detection of long-range chromatin interactions such as loops and interaction frequencies. This data will help determine whether physiologically relevant soft hydrogels alter chromatin organization and mechanosensitive gene regulation compared to conventional rigid plastic cultures, advancing human-based, animal-free cancer models. The contractor is responsible for sample receipt and verification, execution of the Micro-C workflow under standard operating procedures, comprehensive quality control, data generation, and delivery of all analytical outputs in standard formats with accompanying quality flags. Biostatistical support for interpreting the data is included in the service. The government must provide properly labeled, high-quality samples and an accurate manifest in the required format before shipment, and coordinate only after all documentation and agreements are finalized. All work must occur at the contractor’s or Dovetail Genomics LLC-controlled facilities between July 15 and August 31, 2026. Data must be delivered electronically, and the government has 10 business days to accept or reject deliverables; failure to respond within that time results in automatic acceptance. Any deficiencies within the contractor’s control must be corrected within an agreed timeframe. Samples and associated information are strictly protected and used solely for the stated purpose, with no access granted to NIH systems or facilities. The government retains full rights to the generated data for research and reporting, while the contractor must adhere to all confidentiality, sample handling, and destruction protocols outlined in the agreement. This is a total small business set-aside under NAICS code 541715.

General Info

Dovetail will perform Micro-C sequencing on eight samples to study chromatin architecture in colon cancer cells using soft hydrogels.

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

SBA

Documents

1

Requirement+60.docx

DOCX

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more

Requirements:



1. Purpose 


Dovetail Genomics LLC Micro-C service employs micrococcal nuclease (MNase) digestion to generate highly uniform fragments, enabling precise capture of nucleosome positioning with even genomic coverage. This approach provides increased mapping resolution at the nucleosome level, while proximity ligation data enriched for long-range informative reads allows detection of higher-order chromatin organization, including chromatin loops and interaction frequencies. The purpose of this Statement of Work is to acquire Dovetail Genomics LLC Micro-C services for samples processing and associated data generation in support of NCI/CCR/LRBGE research on the effects of substrate stiffness on 3D chromatin architecture in colon cancer cell lines. This information will allow us to better understand the impact of substrate stiffness on gene regulation and cancer cell behavior.  


2. Background 


Mechanical cues regulate cell behavior in development, regeneration, aging, and disease, and in colon cancer, extracellular matrix stiffening may promote malignancy by altering focal adhesions, YAP1 transcription factor activity, invasion, transcriptional programs, and nuclear organization. Given the rising incidence of colorectal cancer in young adults and the NIH emphasis on human-based, animal-free research models, we will compare human colon cancer cells grown on substrates of different stiffnesses to determine whether physiologically relevant soft hydrogels, compared with rigid plastic, alter 3D nuclear architecture assessed by Micro-C. This work will test whether matrix stiffness reshapes chromatin organization and mechanosensitive transcriptional responses in ways that may be missed in conventional culture, supporting more predictive human-based models for cancer biology research. 


Although third-party service contractors may theoretically offer related sample-processing support, they would not provide the same Dovetail Genomics LLC quality micro-C data and may be more expensive while not delivering the same analysis, comparability, or direct platform support required for this project.



3. Scope 


The Contractor shall provide Dovetail Genomics LLC Micro-C Service and analysis for 8 Government-provided samples. Services shall include receipt and accessioning of submitted samples, processing using the Dovetail Genomics LLC protocol, applicable quality control steps, generation of analytical output, delivery of data files and summary documentation, and technical support needed to interpret the generated data within the scope of the quoted service. 




4. Contractor Requirements and Tasks 


  1. Task 1: Project initiation and sample logistics. Coordinate with the Government technical point of contact to confirm sample submission requirements, sample manifest format, shipping instructions, acceptance criteria, and anticipated processing schedule before samples are shipped. 

  1. Task 2: Sample receipt and accessioning. Receive Government-provided samples; verify submitted samples against the Government-provided manifest; notify the Government of any discrepancies, insufficient volume, labeling concerns, shipping deviations, or conditions that may affect assay performance. 

  1. Task 3: Olink Explore HT sample processing. Process accepted samples using the Dovetail Genomics LLC Micto-C Service workflow in accordance with Dovetail Genomics LLC standard operating procedures and applicable quality standards. The Contractor shall use the Dovetail Genomics LLC platform, associated proprietary reagents, workflow, and analysis processes required to generate the requested Micro-C data. 

  1. Task 4: Quality control and data review. Perform applicable assay, sample, and data quality control review. The Contractor shall identify failed samples, quality-control flags, batch concerns, or other limitations relevant to interpretation of the analytical results. 

  1. Task 5: Data delivery. Provide the Government with the data generated from the Dovetail Genomics LLC Service, including supporting files/customary documentation provided with the service. Deliverables shall be provided electronically to the Government technical point of contact. 

  1. Task 6: Technical and biostatistical support. Provide technical consultation associated with the generated Dovetail Genomics LLC, including clarification of output files, quality-control flags, and interpretation of platform-specific analysis outputs. The quoted biostatistical support is included in the cost. 

5. Government Responsibilities 


  • Provide samples suitable for Dovetail Genomics LLC processing, as applicable to the research protocol and internal requirements. 

  • Provide a complete and accurate sample manifest in the format required by Dovetail Genomics LLC before shipment. 

  • Coordinate shipment of samples only after all required agreements, order documentation, and sample submission instructions are in place. 

  • Respond to Contractor questions concerning sample identity, manifest discrepancies, project timing, and deliverable receipt. 

  • Review deliverables and provide acceptance or rejection with specific deficiencies within the timeframe stated in this Statement of Work. 

7. Performance Standards and Acceptance 


  • The Contractor shall perform work using the Dovetail Genomics LLC Micro-C platform and associated standard procedures applicable to the quoted analysis service. 

  • Delivered data must correspond to the Government-provided sample manifest or identify discrepancies that prevent complete attribution. 

  • Delivered files must be accessible electronically in customary Dovetail Genomics LLC output formats and include applicable quality-control information or flags. 

  • The Government will review deliverables within 10 business days after receipt. If no written rejection or deficiency notice is provided within that period, the deliverable may be considered accepted. 

  • If a deliverable is rejected, the Contractor shall correct or explain the deficiency within a mutually agreed timeframe, provided the issue is within the Contractor’s control and within the scope of the service. 

8. Period and Place of Performance 


The requested period of performance is July 15, 2026, through August 31, 2026. Work will be performed at the Contractor’s facility or Dovetail Genomics LLC-controlled facilities appropriate for the Dovetail Genomics LLC Micro-C Service. Government coordination, deliverable review, and data transfer may occur electronically. 


9. Data Rights, Confidentiality, and Sample Handling 


The Contractor shall protect Government-provided samples, manifests, and project information from unauthorized disclosure and shall use them only to perform the required service. Samples shall not be shipped to Dovetail Genomics LLC before execution of required written agreements and completion of required sample submission documentation. Any sample disposition, residual material handling, or return/destruction requirements shall follow the executed agreement and Dovetail Genomics LLC’s applicable terms for analysis services. 


The Government retains rights to use the data generated under this requirement for its research, and reporting, subject to the final contract/order terms. 


10. Security and Privacy 


The Government intends to provide coded research samples and a sample manifest limited to information needed to perform the service. The Contractor shall not receive access to NIH information systems under this SOW. No Contractor personnel will require physical access to NIH facilities or Government-furnished information systems to perform the work, unless separately authorized in writing. 


11. Government-Furnished Property, Equipment, or Information 


The Government will furnish the biological samples and sample manifest required for the service. No Government-furnished equipment or Government-furnished property is anticipated beyond the submitted samples and project information necessary to perform the analysis service. 


More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541690
New
Federal
Clinical Research Support and Collaboration for NHGRI Protocols
Solicitation # 75N98026R00034
The National Institutes of Health Office of Acquisitions and Logistics Management, on behalf of the National Human Genome Research Institute, is soliciting proposals for an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide comprehensive clinical research support and collaboration services. This small business set-aside acquisition focuses on four primary task areas: protocol monitoring and data management, regulatory support for IND and IDE submissions, Data Safety and Monitoring Board (DSMB) support, and statistical expertise. The contractor must provide qualified personnel experienced in clinical trial design and regulatory requirements, with specific expertise in rare diseases, genetic conditions, gene therapy using AAV9 vectors, and both pediatric and adult populations. The contract features a three-year ordering period beginning January 1, 2027, with performance primarily occurring at the contractor's site and some travel to the NIH campus in Bethesda, Maryland. Award will be made on a competitive best value basis using a tradeoff approach, where non-price factors—including personnel, technical and management approach, offeror experience, and past performance—are significantly more important than cost. Task orders will be issued as either firm fixed-price or time and materials. The contract includes stringent requirements for cybersecurity, the handling of Controlled Unclassified Information, and compliance with Section 508 accessibility standards for all electronic deliverables. Proposals are due by November 13, 2026, and must be submitted via the NIH electronic Contract Proposal Submission website in separate technical and business volumes.
Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 17 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS